The Rifaximin Study in CVID
Clinical trial NCT01946906 · COMPLETED
Trial details
- NCT number
- NCT01946906
- Sponsor
- Oslo University Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.